{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:41Z","timestamp":1786123241013,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1213\/ane.0b013e3181c039e6","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T03:14:58Z","timestamp":1258341298000},"page":"1908-1915","source":"Crossref","is-referenced-by-count":91,"title":["Recombinant Activated Factor VII in Obstetric Hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry"],"prefix":"10.1213","volume":"109","author":[{"given":"Louise E.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McLintock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Popham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Jankelowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210902","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review.","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"R2-29-20210902","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","article-title":"Maternal mortality: who, when, where, and why.","volume":"368","author":"Ronsmans","year":"2006","journal-title":"Lancet"},{"key":"R3-29-20210902","article-title":"Maternal deaths in Australia 2000\u20132002. Maternal deaths series no. 2.","author":"Sullivan","year":"2006"},{"key":"R4-29-20210902","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1503\/cmaj.045156","article-title":"Severe maternal morbidity in Canada, 1991\u20132001.","volume":"173","author":"Wen","year":"2005","journal-title":"CMAJ"},{"key":"R5-29-20210902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1467-842X.2006.tb00109.x","article-title":"Trends in postpartum haemorrhage.","volume":"30","author":"Cameron","year":"2006","journal-title":"Aust N Z J Public Health"},{"key":"R6-29-20210902","article-title":"Major conditions associated with childbirth in Australia: Obstetric haemorrhage and associated hysterectomy.","author":"Haynes","year":"2004"},{"key":"R7-29-20210902","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/01.AOG.0000292082.80566.cd","article-title":"Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries.","volume":"110","author":"Grobman","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R8-29-20210902","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1479-828X.2004.00208.x","article-title":"Is placenta accreta catching up with us?","volume":"44","author":"Armstrong","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R9-29-20210902","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications.","volume":"193","author":"Usta","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R10-29-20210902","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clp.2008.07.003","article-title":"Placenta accreta and cesarean scar pregnancy: overlooked costs of the rising cesarean section rate.","volume":"35","author":"Rosen","year":"2008","journal-title":"Clin Perinatol"},{"key":"R11-29-20210902","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1479-828X.2005.00394.x","article-title":"Primary postpartum haemorrhage in an Australian tertiary hospital: a case-control study.","volume":"45","author":"Henry","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R12-29-20210902","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1054\/cuog.2000.0155","article-title":"Massive post-partum haemorrhage.","volume":"11","author":"Macphail","year":"2001","journal-title":"Curr Obstet Gynaecol"},{"key":"R13-29-20210902","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.2006.01018.x","article-title":"Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions.","volume":"113","author":"Bose","year":"2006","journal-title":"BJOG"},{"key":"R14-29-20210902","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1615388","article-title":"Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.","volume":"80","author":"Key","year":"1998","journal-title":"Thromb Haemost"},{"key":"R15-29-20210902","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2516.2003.00782.x","article-title":"Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.","volume":"9","author":"Lloyd Jones","year":"2003","journal-title":"Haemophilia"},{"key":"R16-29-20210902","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001721-199008000-00009","article-title":"Factor VIIa in the treatment of haemophilia.","volume":"1","author":"Hedner","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R17-29-20210902","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor.","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"R18-29-20210902","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R19-29-20210902","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00001721-200306001-00009","article-title":"Analysis and results of the recombinant factor VIIa extended-use registry.","volume":"14","author":"Laffan","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R20-29-20210902","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.athoracsur.2008.05.013","article-title":"Efficacy and safety of recombinant activated Factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials.","volume":"86","author":"Hardy","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R21-29-20210902","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1066022","article-title":"A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.","volume":"34","author":"Franchini","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"R22-29-20210902","first-page":"1174","article-title":"Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.","volume":"101","author":"Bouwmeester","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R23-29-20210902","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.2004.00058.x","article-title":"Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.","volume":"111","author":"Boehlen","year":"2004","journal-title":"BJOG"},{"key":"R24-29-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.0001-6349.2004.00501.x","article-title":"The use of recombinant factor VIIa in severe postpartum hemorrhage.","volume":"83","author":"Segal","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R25-29-20210902","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aei094","article-title":"Recombinant factor VIIa for life-threatening post-partum haemorrhage.","volume":"94","author":"Ahonen","year":"2005","journal-title":"Br J Anaesth"},{"key":"R26-29-20210902","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1399-6576.2007.01323.x","article-title":"An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage.","volume":"51","author":"Ahonen","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R27-29-20210902","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.AOG.0000288515.48066.99","article-title":"Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000\u20132004.","volume":"110","author":"Alfirevic","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R28-29-20210902","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2007.06.022","article-title":"Use of recombinant activated factor VII in massive postpartum haemorrhage.","volume":"137","author":"Bouma","year":"2008","journal-title":"Eur J Obstet Gynecol"},{"key":"R29-29-20210902","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunct therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.","volume":"59","author":"Boffard","year":"2005","journal-title":"J Trauma"},{"key":"R30-29-20210902","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-5994.2007.01472.x","article-title":"Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.","volume":"38","author":"Isbister","year":"2008","journal-title":"Intern Med J"},{"key":"R31-29-20210902","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.injury.2007.05.003","article-title":"The use of recombinant activated factor VII in trauma patients: experience from the Australian and New Zealand haemostasis registry.","volume":"38","author":"Cameron","year":"2007","journal-title":"Injury"},{"key":"R32-29-20210902","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1751-2824.2007.00123.x","article-title":"The Australasian haemostasis register for clinical use of recombinant activated factor VII.","volume":"2","author":"Isbister","year":"2007","journal-title":"ISBT Sci Series"},{"key":"R33-29-20210902","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.athoracsur.2007.06.076","article-title":"Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.","volume":"85","author":"Dunkley","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R34-29-20210902","first-page":"1659","article-title":"Diffusion-weighted imaging in the setting of diffuse cortical laminar necrosis and hypoxic-ischaemic encephalopathy.","volume":"25","author":"McKinney","year":"2004","journal-title":"Am J Neuroradiol"},{"key":"R35-29-20210902","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1471-0528.2007.01507.x","article-title":"Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage.","volume":"114","author":"Knight","year":"2007","journal-title":"BJOG"},{"key":"R36-29-20210902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1423-0410.2005.00711.x","article-title":"Recombinant activated factor VII (rFVIIa\/ NovoSeven(R)) in intractable haemorrhage: use of a clinical scoring system to predict outcome.","volume":"90","author":"Biss","year":"2006","journal-title":"Vox Sang"},{"key":"R37-29-20210902","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2007.06.022","article-title":"Use of recombinant activated factor VII in massive postpartum haemorrhage.","volume":"137","author":"Bouma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R38-29-20210902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1423-0410.2004.00533.x","article-title":"Recombinant activated factor VII (NovoSeven (TM)): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.","volume":"87","author":"Mayo","year":"2004","journal-title":"Vox Sang"},{"key":"R39-29-20210902","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jgyn.2006.09.002","article-title":"Life threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use.","volume":"36","author":"Courtois","year":"2007","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"R40-29-20210902","first-page":"230","article-title":"[Effect of recombinant activated factor VII (rFVIIa; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].","volume":"73","author":"Sobieszczyk","year":"2002","journal-title":"Ginekol Pol"},{"key":"R41-29-20210902","first-page":"21","article-title":"Efficacy of recombinant activated factor VII (rFVIIa, NovoSeven\u00ae) in prenatal medicine.","volume":"8","author":"Breborowicz","year":"2002","journal-title":"Arch Perinat Med"},{"key":"R42-29-20210902","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"R43-29-20210902","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage.","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"R44-29-20210902","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.20470","article-title":"Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.","volume":"11","author":"Lodge","year":"2005","journal-title":"Liver Transpl"},{"key":"R45-29-20210902","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00000542-200502000-00006","article-title":"Recombinant coagulation factor VIIa in major liver resection.","volume":"102","author":"Lodge","year":"2005","journal-title":"Anesthesiology"},{"key":"R46-29-20210902","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/bja\/aei102","article-title":"Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.","volume":"94","author":"Raobaikady","year":"2005","journal-title":"Br J Anaesth"},{"key":"R47-29-20210902","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.20458","article-title":"Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.","volume":"11","author":"Planinsic","year":"2005","journal-title":"Liver Transpl"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181c039e6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:29:02Z","timestamp":1786112942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200912000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181c039e6","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}